[Federal Register Volume 66, Number 139 (Thursday, July 19, 2001)]
[Notices]
[Page 37656]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-18011]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Patent Application Concerning Anthrax Vaccines

AGENCY: U.S. Army Medical Research and Material Command, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6, announcement is made of the 
availability for licensing of U.S. Patent Application Serial No. 09/
350,729 entitled ``Anthrax Vaccines'' and filed July 9, 1999. Foreign 
rights are also available (PCT/US99/15568). This patent application has 
been assigned to the United States Government as represented by the 
Secretary of the Army.

ADDRESSES: Commander, U.S. Army Medical Research and Material Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, Maryland 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664. Both 
at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: Using the nontoxic PA protein from B. 
anthracis, a method and composition for use in inducing an immune 
response which is protective against anthrax in subjects is described.

Luz D. Ortiz,
Army Federal Register Liaison Officer.
[FR Doc. 01-18011 Filed 7-18-01; 8:45 am]
BILLING CODE 3710-08-M